Search research articles
Contact Us
Filters
Showing results (91-100 of 142) with videos related to
Page
of 15
Sort By:
Blood
|
February 15, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells
R M Lemoli, A Fortuna, M R Motta, et al.
Bone Marrow Transplantation
|
July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
M Cavo, G Bandini, M Benni, et al.
Annals of Hematology
|
May 21, 2024
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes
Francesca Palandri, F Branzanti, M Venturi, et al.
Journal of Cancer Research and Clinical Oncology
|
October 9, 2025
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, et al.
Leukemia
|
October 8, 2015
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
M Cavo, L Pantani, A Pezzi, et al.
Leukemia
|
August 27, 2013
IMWG consensus on risk stratification in multiple myeloma
W J Chng, A Dispenzieri, C-S Chim, et al.
British Journal of Haematology
|
December 3, 1999
Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study
R M Lemoli, G Martinelli, A Olivieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
Journal of Bone Oncology
|
March 24, 2025
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
M Talarico, S Barbato, A Cattabriga, et al.
Haematologica
|
May 16, 1998
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation
R M Lemoli, G Bandini, G Leopardi, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 142) with videos related to
Sort By:
Page
of 15
Blood
|
February 15, 1996
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells
R M Lemoli, A Fortuna, M R Motta, et al.
Bone Marrow Transplantation
|
July 25, 1998
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
M Cavo, G Bandini, M Benni, et al.
Annals of Hematology
|
May 21, 2024
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes
Francesca Palandri, F Branzanti, M Venturi, et al.
Journal of Cancer Research and Clinical Oncology
|
October 9, 2025
Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?
M Talarico, S Barbato, V Maisnar, et al.
Leukemia
|
October 8, 2015
Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
M Cavo, L Pantani, A Pezzi, et al.
Leukemia
|
August 27, 2013
IMWG consensus on risk stratification in multiple myeloma
W J Chng, A Dispenzieri, C-S Chim, et al.
British Journal of Haematology
|
December 3, 1999
Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study
R M Lemoli, G Martinelli, A Olivieri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
E Terpos, O Sezer, P I Croucher, et al.
Journal of Bone Oncology
|
March 24, 2025
Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma
M Talarico, S Barbato, A Cattabriga, et al.
Haematologica
|
May 16, 1998
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation
R M Lemoli, G Bandini, G Leopardi, et al.
Page
of 15